{"id":"https://openalex.org/W4416636436","doi":"https://doi.org/10.1183/13993003.congress-2025.pa6071","title":"Immune checkpoint inhibitor-related pneumonitis in lung cancer patients: a retrospective analysis of severity and outcomes","display_name":"Immune checkpoint inhibitor-related pneumonitis in lung cancer patients: a retrospective analysis of severity and outcomes","publication_year":2025,"publication_date":"2025-09-27","ids":{"openalex":"https://openalex.org/W4416636436","doi":"https://doi.org/10.1183/13993003.congress-2025.pa6071"},"language":null,"primary_location":{"id":"doi:10.1183/13993003.congress-2025.pa6071","doi":"https://doi.org/10.1183/13993003.congress-2025.pa6071","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa6071","pdf_url":null,"source":{"id":"https://openalex.org/S100767427","display_name":"Lung Cancer","issn_l":"0169-5002","issn":["0169-5002","1872-8332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lung cancer","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Giacomo Guglielmi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giacomo Guglielmi","raw_affiliation_strings":["1Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa- Pisa Italy, Livorno, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa- Pisa Italy, Livorno, Italy","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013433148","display_name":"Iacopo Petrini","orcid":"https://orcid.org/0000-0002-7752-6866","observed_orcids":["https://orcid.org/0000-0002-7752-6866"]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Iacopo Petrini","raw_affiliation_strings":["2Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa- Pisa Italy, Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa- Pisa Italy, Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012508480","display_name":"Andrea Sbrana","orcid":"https://orcid.org/0000-0003-4460-5282","observed_orcids":["https://orcid.org/0000-0003-4460-5282"]},"institutions":[{"id":"https://openalex.org/I4210165410","display_name":"Azienda Ospedaliera Universitaria Pisana","ror":"https://ror.org/05xrcj819","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210165410"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Andrea Sbrana","raw_affiliation_strings":["3Pulmonary Unit, Cardiothoracic and Vascular Department, Pisa University Hospital - Pisa Italy, Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Pulmonary Unit, Cardiothoracic and Vascular Department, Pisa University Hospital - Pisa Italy, Pisa, Italy","institution_ids":["https://openalex.org/I4210165410"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042003654","display_name":"Davide Chimera","orcid":"https://orcid.org/0000-0002-2315-4083","observed_orcids":["https://orcid.org/0000-0002-2315-4083"]},"institutions":[{"id":"https://openalex.org/I4210165410","display_name":"Azienda Ospedaliera Universitaria Pisana","ror":"https://ror.org/05xrcj819","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210165410"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Davide Chimera","raw_affiliation_strings":["3Pulmonary Unit, Cardiothoracic and Vascular Department, Pisa University Hospital - Pisa Italy, Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Pulmonary Unit, Cardiothoracic and Vascular Department, Pisa University Hospital - Pisa Italy, Pisa, Italy","institution_ids":["https://openalex.org/I4210165410"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073200264","display_name":"Laura Maria Tavanti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165410","display_name":"Azienda Ospedaliera Universitaria Pisana","ror":"https://ror.org/05xrcj819","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210165410"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Laura Tavanti","raw_affiliation_strings":["3Pulmonary Unit, Cardiothoracic and Vascular Department, Pisa University Hospital - Pisa Italy, Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Pulmonary Unit, Cardiothoracic and Vascular Department, Pisa University Hospital - Pisa Italy, Pisa, Italy","institution_ids":["https://openalex.org/I4210165410"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023852055","display_name":"Francesco Pistelli","orcid":"https://orcid.org/0000-0001-5612-6364","observed_orcids":["https://orcid.org/0000-0001-5612-6364"]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Pistelli","raw_affiliation_strings":["4Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa- Pisa Italy, Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa- Pisa Italy, Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109966494","display_name":"Laura Carrozzi","orcid":"https://orcid.org/0000-0001-6953-4527","observed_orcids":["https://orcid.org/0000-0001-6953-4527"]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Laura Carrozzi","raw_affiliation_strings":["4Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa- Pisa Italy, Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa- Pisa Italy, Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009252773","display_name":"Gianluca Marchi","orcid":"https://orcid.org/0009-0000-6122-7792","observed_orcids":["https://orcid.org/0009-0000-6122-7792"]},"institutions":[{"id":"https://openalex.org/I4210165410","display_name":"Azienda Ospedaliera Universitaria Pisana","ror":"https://ror.org/05xrcj819","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210165410"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Guido Marchi","raw_affiliation_strings":["3Pulmonary Unit, Cardiothoracic and Vascular Department, Pisa University Hospital - Pisa Italy, Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Pulmonary Unit, Cardiothoracic and Vascular Department, Pisa University Hospital - Pisa Italy, Pisa, Italy","institution_ids":["https://openalex.org/I4210165410"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3390,"currency":"USD","value_usd":3390},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA6071","last_page":"PA6071"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-related-pneumonitis","display_name":"immune-related pneumonitis","score":0.8920000195503235},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9900000095367432},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.7799999713897705},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.6470000147819519},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":1.0}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9679999947547913},{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.9286999702453613},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.8640999794006348},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8579000234603882},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.8557000160217285},{"id":"https://openalex.org/C2779524853","wikidata":"https://www.wikidata.org/wiki/Q1284347","display_name":"Pneumonitis","level":3,"score":0.8230999708175659},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6833000183105469},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6757000088691711},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5540000200271606},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.4952999949455261},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49399998784065247},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4097000062465668},{"id":"https://openalex.org/C179585855","wikidata":"https://www.wikidata.org/wiki/Q203337","display_name":"Pulmonology","level":2,"score":0.3953999876976013},{"id":"https://openalex.org/C2777134676","wikidata":"https://www.wikidata.org/wiki/Q35890","display_name":"Hypersensitivity pneumonitis","level":3,"score":0.350600004196167},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.33799999952316284},{"id":"https://openalex.org/C179755657","wikidata":"https://www.wikidata.org/wiki/Q58702","display_name":"Mortality rate","level":2,"score":0.3224000036716461},{"id":"https://openalex.org/C2777914695","wikidata":"https://www.wikidata.org/wiki/Q12192","display_name":"Pneumonia","level":2,"score":0.3041999936103821},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.29170000553131104},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2890999913215637},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2849000096321106},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.2784999907016754},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.26829999685287476},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.26100000739097595},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.258899986743927},{"id":"https://openalex.org/C2776376669","wikidata":"https://www.wikidata.org/wiki/Q5094647","display_name":"Intensive care unit","level":2,"score":0.25380000472068787}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2025.pa6071","doi":"https://doi.org/10.1183/13993003.congress-2025.pa6071","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa6071","pdf_url":null,"source":{"id":"https://openalex.org/S100767427","display_name":"Lung Cancer","issn_l":"0169-5002","issn":["0169-5002","1872-8332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lung cancer","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Background:":[0],"Immune":[1],"checkpoint":[2],"inhibitors":[3],"(ICIs)":[4],"have":[5],"transformed":[6],"lung":[7,44,202],"cancer":[8,45,203],"therapy.":[9],"However,":[10],"despite":[11],"their":[12],"clinical":[13,37,87],"benefits,ICIs":[14],"may":[15],"induce":[16],"immune-related":[17],"adverse":[18],"events":[19],"(irAEs),":[20],"with":[21,114,174],"pneumonitis":[22,50,79],"being":[23],"one":[24],"of":[25,29,58,72,92,111,168,193],"the":[26,35,69,90,101,140,211],"leading":[27],"causes":[28],"ICI-associated":[30],"mortality.":[31],"Aim:":[32],"To":[33],"evaluate":[34,100],"severity,":[36],"outcomes,":[38,88],"and":[39,89,106,127,159,170,185,232],"treatment":[40],"resumption":[41],"rates":[42],"in":[43,166,191,201],"patients":[46,113],"who":[47],"developed":[48],"ICI-related":[49],"(CIP).":[51],"Methods:":[52],"We":[53],"conducted":[54],"a":[55,198],"retrospective":[56],"review":[57],"CIP":[59,104,115,134,144,176,196,226],"cases":[60,169,207],"diagnosed":[61],"from":[62],"September":[63],"2018":[64],"to":[65,83,99,133,221],"March":[66],"2024":[67],"at":[68],"Pulmonology":[70],"Unit":[71],"Pisa":[73],"University":[74],"Hospital.Data":[75],"were":[76,116,120],"collected":[77],"regarding":[78],"severity":[80,105,145,177],"(graded":[81],"according":[82],"NCI-CTCAE":[84],"version":[85],"5.0),":[86],"rate":[91],"ICI":[93,142,186,235],"resumption.Fisher\u2019s":[94],"exact":[95],"test":[96],"was":[97,136,146,164,171,183,188],"used":[98],"association":[102],"between":[103],"hospitalization.":[107],"Results:":[108],"A":[109],"total":[110],"21":[112],"identified.The":[117],"causative":[118],"ICIs":[119],"Pembrolizumab":[121],"(47%),":[122],"Nivolumab":[123],"(24%),":[124],"Atezolizumab":[125],"(15%),":[126],"Durvalumab":[128],"(14%).":[129],"The":[130],"median":[131],"time":[132],"onset":[135],"29":[137],"weeks":[138],"after":[139],"initial":[141],"dose.":[143],"distributed":[147],"as":[148],"follows:":[149],"Grade":[150,153,156,160],"1":[151],"(38.1%),":[152],"2":[154],"(33.4%),":[155],"3":[157],"(23.8%),":[158],"4":[161],"(4.7%).":[162],"Hospitalization":[163],"required":[165],"23.8%":[167],"significantly":[172],"associated":[173],"higher":[175],"(p":[178],"<":[179],"0.0003).":[180],"Overall":[181],"mortality":[182,213],"4.7%,":[184],"therapy":[187],"successfully":[189],"resumed":[190],"66.6%":[192],"patients.":[194,204],"Conclusions:":[195],"remains":[197,214],"significant":[199],"challenge":[200],"While":[205],"severe":[206],"often":[208],"necessitate":[209],"hospitalization,":[210],"overall":[212],"low":[215],"(<5%).":[216],"Further":[217],"research":[218],"is":[219],"needed":[220],"assess":[222],"real-world":[223],"incidence,":[224],"identify":[225],"risk":[227],"factors,":[228],"refine":[229],"management":[230],"strategies,":[231],"facilitate":[233],"safe":[234],"resumption.":[236]},"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2025-11-25T00:00:00"}